Actively Recruiting
Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer
Led by Centro di Riferimento Oncologico - Aviano · Updated on 2024-12-17
1500
Participants Needed
4
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Accurate assessment of axillary lymph nodes in patients with breast cancer is essential for prognosis and treatment planning. Staging and surgical management have evolved from axillary lymph node dissection to sentinel lymph node biopsy to minimize morbidity. However, sentinel lymph node biopsy has non-negligible morbidity, and more than 70% of biopsies are negative, calling into question its routine use. Magnetic resonance imaging (MRI) can be used to detect and stage lymph node metastases in situ, but its sensitivity and specificity are moderate to poor. Few studies have employed artificial intelligence to detect lymph node metastases on MRI images, and none have used an integrative multidata approach (IMA), defined as modeling the combination of clinical and laboratory data with multiparametric MRI. The primary objective of this retrospective observational study is to improve the accuracy of detecting lymph node involvement in breast cancer using IMA. The secondary objective is to allow longitudinal monitoring of the effects of neoadjuvant therapy on lymph node involvement
CONDITIONS
Official Title
Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with breast cancer who underwent MRI and biopsy or surgery of axillary lymph nodes as part of their diagnosis and treatment
- Patients of all genders, ages, and stage I-III of breast cancer
- Patients who underwent neoadjuvant therapy and have longitudinal imaging data available for analysis (for secondary outcome analysis)
You will not qualify if you...
- Patients whose MRI images were of insufficient quality for analysis
- Patients who had a previous history of breast cancer
- Patients with a history of axillary surgery or lymph node dissection prior to the current diagnosis of breast cancer
- Patients who received neoadjuvant therapy at another institution
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Landeskrankenhaus Villach
Villach, Austria, 9500
Actively Recruiting
2
KI4LIFE, Fraunhofer Austria Research
Austria, Austria, Italy, 9020
Actively Recruiting
3
Klinikum Klagenfurt am Wörthersee Klagenfurt am Wörthersee
Villach, Austria, Italy, 9500
Actively Recruiting
4
Centro di Riferimento Oncologico
Aviano, Pordenone, Italy, 33081
Actively Recruiting
Research Team
F
Fabio Del Ben, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here